AMPLIFYing NEOepitope-specific VACcine Responses in Progressive Diffuse Glioma
Clinical trial NCT03893903 · COMPLETED
Trial details
- NCT number
- NCT03893903
- Sponsor
- German Cancer Research Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-19
- Primary completion
- 2024-09-20
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.